The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

Toward individualized breast cancer screening strategies—TMIST

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

On behalf of the ECOG-ACRIN Cancer Research Group

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Etta D. Pisano, MD
Principal investigator, TMIST
Professor in Residence of Radiology, Beth Israel Deaconess Medical Center
Constantine A. Gatsonis, PhD
Henry Ledyard Goddard University Professor of Biostatistics, Chair, Department of Biostatistics, Brown University
Peter J. O'Dwyer, MD
Group co-chair, director, ECOG-ACRIN Cancer Research Group, Developmental Therapeutics Program, Abramson Cancer Center, professor of medicine, Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia
Mitchell D. Schnall, MD, PhD
Group co-chair, ECOG-ACRIN Cancer Research Group; Eugene P. Pendergrass Professor of Radiology, The Perelman School of Medicine, University of Pennsylvania
Table of Contents

YOU MAY BE INTERESTED IN

Cancer History ProjectGuest Editorial

At Lung SPORE Workshop, experts reflect on the significance of discovery of EGFR mutations two decades ago

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.
By Katerina A. Politi and Roy S. Herbst
Byline
Etta D. Pisano, MD
Principal investigator, TMIST
Professor in Residence of Radiology, Beth Israel Deaconess Medical Center
Constantine A. Gatsonis, PhD
Henry Ledyard Goddard University Professor of Biostatistics, Chair, Department of Biostatistics, Brown University
Peter J. O'Dwyer, MD
Group co-chair, director, ECOG-ACRIN Cancer Research Group, Developmental Therapeutics Program, Abramson Cancer Center, professor of medicine, Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia
Mitchell D. Schnall, MD, PhD
Group co-chair, ECOG-ACRIN Cancer Research Group; Eugene P. Pendergrass Professor of Radiology, The Perelman School of Medicine, University of Pennsylvania
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account